vs
Side-by-side financial comparison of RHYTHM PHARMACEUTICALS, INC. (RYTM) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($60.1M vs $35.3M, roughly 1.7× UNITY BANCORP INC). UNITY BANCORP INC runs the higher net margin — 43.9% vs -92.6%, a 136.4% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (83.8% vs 24.2%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (43.8% CAGR vs 17.5%).
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.
RYTM vs UNTY — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $60.1M | $35.3M |
| Net Profit | $-55.6M | $15.5M |
| Gross Margin | 88.1% | — |
| Operating Margin | -87.1% | 55.8% |
| Net Margin | -92.6% | 43.9% |
| Revenue YoY | 83.8% | 24.2% |
| Net Profit YoY | — | 34.5% |
| EPS (diluted) | $-0.83 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $60.1M | — | ||
| Q4 25 | $57.3M | $35.3M | ||
| Q3 25 | $51.3M | $32.8M | ||
| Q2 25 | $48.5M | $34.4M | ||
| Q1 25 | $32.7M | $29.4M | ||
| Q4 24 | $41.8M | $28.4M | ||
| Q3 24 | $33.3M | $27.7M | ||
| Q2 24 | $29.1M | $25.5M |
| Q1 26 | $-55.6M | — | ||
| Q4 25 | $-47.5M | $15.5M | ||
| Q3 25 | $-52.9M | $14.4M | ||
| Q2 25 | $-46.6M | $16.5M | ||
| Q1 25 | $-49.5M | $11.6M | ||
| Q4 24 | $-43.3M | $11.5M | ||
| Q3 24 | $-43.6M | $10.9M | ||
| Q2 24 | $-32.3M | $9.5M |
| Q1 26 | 88.1% | — | ||
| Q4 25 | 91.6% | — | ||
| Q3 25 | 89.3% | — | ||
| Q2 25 | 88.6% | — | ||
| Q1 25 | 88.8% | — | ||
| Q4 24 | 90.9% | — | ||
| Q3 24 | 88.5% | — | ||
| Q2 24 | 89.9% | — |
| Q1 26 | -87.1% | — | ||
| Q4 25 | -82.2% | 55.8% | ||
| Q3 25 | -102.6% | 57.5% | ||
| Q2 25 | -93.4% | 62.6% | ||
| Q1 25 | -143.7% | 52.6% | ||
| Q4 24 | -98.6% | 51.0% | ||
| Q3 24 | -132.0% | 52.7% | ||
| Q2 24 | -139.2% | 49.3% |
| Q1 26 | -92.6% | — | ||
| Q4 25 | -83.0% | 43.9% | ||
| Q3 25 | -103.1% | 43.8% | ||
| Q2 25 | -96.1% | 48.0% | ||
| Q1 25 | -151.4% | 39.5% | ||
| Q4 24 | -103.6% | 40.5% | ||
| Q3 24 | -131.2% | 39.4% | ||
| Q2 24 | -110.9% | 37.1% |
| Q1 26 | $-0.83 | — | ||
| Q4 25 | $-0.73 | $1.52 | ||
| Q3 25 | $-0.82 | $1.41 | ||
| Q2 25 | $-0.75 | $1.61 | ||
| Q1 25 | $-0.81 | $1.13 | ||
| Q4 24 | $-0.71 | $1.13 | ||
| Q3 24 | $-0.73 | $1.07 | ||
| Q2 24 | $-0.55 | $0.92 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $340.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $122.9M | $345.6M |
| Total Assets | $442.3M | $3.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $340.6M | — | ||
| Q4 25 | $388.9M | — | ||
| Q3 25 | $416.1M | — | ||
| Q2 25 | $291.0M | — | ||
| Q1 25 | $314.5M | — | ||
| Q4 24 | $320.6M | — | ||
| Q3 24 | $298.4M | — | ||
| Q2 24 | $319.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $230.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $122.9M | — | ||
| Q4 25 | $139.1M | $345.6M | ||
| Q3 25 | $148.8M | $334.0M | ||
| Q2 25 | $-11.9M | $319.8M | ||
| Q1 25 | $18.9M | $306.1M | ||
| Q4 24 | $21.7M | $295.6M | ||
| Q3 24 | $11.2M | $284.3M | ||
| Q2 24 | $39.3M | $273.4M |
| Q1 26 | $442.3M | — | ||
| Q4 25 | $480.2M | $3.0B | ||
| Q3 25 | $506.9M | $2.9B | ||
| Q2 25 | $372.7M | $2.9B | ||
| Q1 25 | $386.7M | $2.8B | ||
| Q4 24 | $392.3M | $2.7B | ||
| Q3 24 | $363.6M | $2.6B | ||
| Q2 24 | $381.8M | $2.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $44.9M |
| Free Cash FlowOCF − Capex | — | $44.3M |
| FCF MarginFCF / Revenue | — | 125.7% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | — | 2.90× |
| TTM Free Cash FlowTrailing 4 quarters | — | $81.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-25.4M | $44.9M | ||
| Q3 25 | $-26.6M | $45.5M | ||
| Q2 25 | $-23.3M | $-25.3M | ||
| Q1 25 | $-40.4M | $17.9M | ||
| Q4 24 | $-18.8M | $48.0M | ||
| Q3 24 | $-25.2M | $17.7M | ||
| Q2 24 | $-29.1M | $-8.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $44.3M | ||
| Q3 25 | — | $45.3M | ||
| Q2 25 | — | $-25.5M | ||
| Q1 25 | — | $17.6M | ||
| Q4 24 | — | $47.3M | ||
| Q3 24 | — | $17.5M | ||
| Q2 24 | — | $-8.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 125.7% | ||
| Q3 25 | — | 138.1% | ||
| Q2 25 | — | -74.2% | ||
| Q1 25 | — | 59.9% | ||
| Q4 24 | — | 166.5% | ||
| Q3 24 | — | 63.3% | ||
| Q2 24 | — | -33.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.90× | ||
| Q3 25 | — | 3.16× | ||
| Q2 25 | — | -1.54× | ||
| Q1 25 | — | 1.54× | ||
| Q4 24 | — | 4.17× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | -0.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
